Skip to content

Top 5 HIV treatment stories from IAS 2023

Rhiannon Neale Photography

Integrase inhibitors more likely to be linked to depression and suicidality than other HIV drugs

Tero Vesalainen/Shutterstock.com

Top 5 stories on HIV in Africa from IAS 2023

Shutterstock Studios HIV in View gallery

Mumbai shows triaging those with advanced HIV disease in government centres is feasible

Luvin Yash/Shutterstock.com

People with HIV remain at higher risk of dying from COVID-19 in the Omicron era

sqofield/Shutterstock.com

Integrase inhibitors raise the risk of diabetes regardless of weight gain

Dhanushi Rupasinghe at IAS 2023.

Statins and HIV: how can the REPRIEVE findings be implemented in the real world?

The REPRIEVE trial symposium panel discussion at IAS 2023. Photo by @iasociety.

Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment programmes

Professor Francois Venter at IAS 2023. Photo by Roger Pebody.

COVID-19 vaccine effectiveness lower in people with HIV who inject drugs

Dr Joseph Puyat at IAS 2023.